1. Aslan A, Khorami R, Rezaii J, Godarzi M, Abbasi DZ. Drug updates for prevention and treatment of venous thromboembolism in orthopedic surgeries. Iranian J Cardiovasc Nurs. 2017;6(2):66–73.
2. Beckman MG, Abe K, Barnes K, Bartman B, Brady PJ, Hooper WC. Strategies and partnerships toward prevention of healthcare-associated venous thromboembolism. J Hosp Med. 2016;11(Suppl 2):S5.
3. Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual Saf. 2013;22(10):809–15.
4. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J Cardiovasc Pharmacother. 2014;35(43):3033–73.
5. Heisen M, Treur MJ, Heemstra HE, Giesen EB, Postma MJ. Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands. J Med Econ. 2017;20(8):813–24.